[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345343-105":59,"doc-detail-345343-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-specific-lncrna-igf1r-as1-transregulates-chromatin-interactions-associated-with-oncogenic-myc-signaling","Tumor-specific lncRNA IGF1R-AS1 transregulates chromatin interactions associated with oncogenic MYC signaling","","Tumor-specific lncRNA IGF1R-AS1 is investigated as a regulator of oncogenic MYC signaling through effects on 3D chromatin architecture. The study analyzes lncRNA expression in metastatic castration-resistant prostate cancer patients and identifies 1344 lncRNAs, with IGF1R-AS1 showing the strongest super-enhancer association. Pancancer transcriptome analysis shows tumor-specific transcription and overexpression in prostate and lung cancers. Functionally, IGF1R-AS1 engages chromatin remodeling complexes to promote long-range enhancer-promoter looping, driving MYC overexpression and enhanced tumorigenicity, without cis effects on IGF1R expression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-specific-lncrna-igf1r-as1-transregulates-chromatin-interactions-associated-with-oncogenic-myc-signaling/345343/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-specific-lncrna-igf1r-as1-transregulates-chromatin-interactions-associated-with-oncogenic-myc-signaling/345343.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus regarding IGF1R-AS1 and cancer progression?","Question",{"text":112,"@type":113},"The article studies how the tumor-specific lncRNA IGF1R-AS1 regulates oncogenic MYC signaling. It links IGF1R-AS1 to long-range chromatin interactions that support MYC overexpression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was IGF1R-AS1 identified in the study?",{"text":117,"@type":113},"LncRNA expression was comprehensively analyzed in a cohort of metastatic castration-resistant prostate cancer patients. The analysis found 1344 lncRNAs and highlighted IGF1R-AS1 as having the strongest super-enhancer association.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism does the study propose for IGF1R-AS1 action?",{"text":121,"@type":113},"The study proposes a non-canonical trans-acting role where IGF1R-AS1 interacts with chromatin remodeling complexes and architectural proteins. This facilitates long-range chromatin looping between distal MYC enhancers and its promoter.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345343,1790663788,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article [https://doi.org/10.1038/s41467-026-70814-4](https://doi.org/10.1038/s41467-026-70814-4)  \nTumor-speciﬁc lncRNA IGF1R-AS1 transregulates chromatin interactions associated with oncogenic MYC signaling  \nReceived: 11 May 2025  \n\n| Accepted: 6 March 2026 |\n| --- |\n| |\n| Check for updates |\n\nYongyong Yang1,13, Ting-You Wang 1,13, Joshua Fry 1,2,13, Yingming Li3,13, Qingshu Meng 1,13, Qingxiang Guo 1, Nathan E. Patchen4, Kyle H. White  Abhirami Ramakrishnan 1, Yanan Ren1, Qianru Li6, Xingxing Zhang1, Taufeeque Ali1, Courtney Dawes 4, Stamatina Fragkogianni7, Parker Irvin5,  \n5,12 ,  \nSk Kayum Alam 8, Luke H. Hoeppner 3,8, Xihong Zhang3, Douglas Yee 3  \n,  \nAdam B. Weiner9, Edward M. Schaeffer 1, Yang Liu 4, Xiaoyang Zhang5, Scott M. Dehm 3,10 , Qi Cao 1,11  & Rendong Yang 1,11   \nLncRNAs have emerged as pivotal regulators in the development and progression of various human cancers. However, understanding the precise mechanisms by which lncRNAs inﬂuence cancer progression remains a substantial challenge, largely due to their cell type-and tissue-speciﬁc expression patterns and the lack of well-deﬁned functional domains or motifs. In this study, we investigate the complex interplay between super-enhancers and lncRNAs through a comprehensive analysis of lncRNA expression in a cohort of metastatic castration-resistant prostate cancer patients. Our analysis identiﬁes 1344 lncRNAs, among which an antisense lncRNA in the IGF1R locus named IGF1R-AS1 displayed the strongest super-enhancer association. Through pancancer transcriptome analysis, we ﬁnd that IGF1R-AS1 is speciﬁcally transcribed in tumor specimens and is overexpressed in prostate and lung cancers. Notably, we reveal a non-canonical trans-acting role for IGF1R-AS1 whereby it interacts with chromatin remodeling complexes and architectural proteins to facilitate long-range chromatin looping between distal MYC enhancers and its promoter, leading to MYC overexpression and enhanced tumorigenicity. Collectively, our ﬁndings elucidate a mechanism by which a tumor-speciﬁc transacting lncRNA modulates oncogenic MYC expression through long-range chromatin interactions, suggesting IGF1R-AS1 may play an important role in the pathogenesis of MYC-driven malignancies.  \nLong non-coding RNAs (lncRNAs) play critical roles in the regulation of gene expression, particularly in cancer progression and lineagespeciﬁc oncogenic programs1. While high-throughput transcriptomic studies have uncovered thousands of lncRNAs, their context-speciﬁc functions and regulatory mechanisms remain incompletely understood. Many well-characterized cancer-associated lncRNAs, such as  \nMALAT1, HOTAIR, and NEAT1, are broadly expressed across both normal and tumor tissues2. In contrast, some lncRNAs exhibit highly tissue- or tumor-speciﬁc expression patterns and tend to act locally (incis), especially at super-enhancer regions where they can promote chromatin looping and transcriptional activation of nearby oncogenes3. For example, the colorectal cancer-associated lncRNA  \nA full list of afﬁliations appears at the end of the paper. e-mail: [dehm@umn.edu](dehm@umn.edu); [qi.cao@northwestern.edu](qi.cao@northwestern.edu); [rendong.yang@northwestern.edu](rendong.yang@northwestern.edu)  \nCCAT1, transcribed from a super-enhancer upstream of MYC, facilitates enhancer-promoter interactions that drive MYC overexpression4.  \nDespite such advances, the landscape of lncRNAs with tumorspeciﬁc expression, those absent in normal tissues but selectively activated in cancer, remains poorly characterized. This class of lncRNAs holds particular promise for cancer-speciﬁc targeting but is often missed in annotation databases due to their selective expression in tumor contexts5. A deeper understanding of tumor-speciﬁclncRNAsand their mechanisms of action may offer unique opportunities for therapeutic intervention and disease monitoring.  \nWhile certain tumor-speciﬁc lncRNAs with cis-regulatory functions have been well characterized, t","cbCaihR3cLadKdZu","https://ap.wps.com/l/cbCaihR3cLadKdZu","pdf",6962038,"English","# Results\n## Discovery of lncRNAs from transcriptome analysis of mCRPC","[{\"question\":\"What is the main focus regarding IGF1R-AS1 and cancer progression?\",\"answer\":\"The article studies how the tumor-specific lncRNA IGF1R-AS1 regulates oncogenic MYC signaling. It links IGF1R-AS1 to long-range chromatin interactions that support MYC overexpression.\"},{\"question\":\"How was IGF1R-AS1 identified in the study?\",\"answer\":\"LncRNA expression was comprehensively analyzed in a cohort of metastatic castration-resistant prostate cancer patients. The analysis found 1344 lncRNAs and highlighted IGF1R-AS1 as having the strongest super-enhancer association.\"},{\"question\":\"What mechanism does the study propose for IGF1R-AS1 action?\",\"answer\":\"The study proposes a non-canonical trans-acting role where IGF1R-AS1 interacts with chromatin remodeling complexes and architectural proteins. This facilitates long-range chromatin looping between distal MYC enhancers and its promoter.\"}]","Tumor-specific lncRNA IGF1R-AS1 transregulates chromatin interactions associated with oncogenic MYC signaling | PDF",1790057369,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82530f5da65c757d89423735ea137d6c.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d5df5b44fd23abb464b737d789f5486.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0ea1d1cd360d587445157922ffd86d5.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92d7b523b11fd3435371d44bfd9b052d.webp",980,1301]